Dec 18 (Reuters) - SenzaGen AB SENZA.ST :
* SENZAGEN SECURES SEK 1.7M ORDER FROM A NEW GLOBAL BIOTECH
INDUSTRY LEADER
* CUSTOMER IS A GLOBAL LEADER IN BIOTECH WITH A SIGNIFICANT
PRESENCE AND RESEARCH IN VARIOUS CHEMICAL AREAS
* TESTS WILL BE CONDUCTED AT COMPANY'S GLP-CERTIFIED
LABORATORIES
IN LUND AND AT SUBSIDIARY, VITROSCREEN, IN MILAN DURING Q4 OF
2023 AND Q1 OF 2024
Source text for Eikon: ID:nMFNczlHJ
Further company coverage: SENZA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))